Literature DB >> 6306216

Affinity of normorphine for its pharmacologic receptor in the naive and morphine-tolerant guinea-pig isolated ileum.

F Porreca, T F Burks.   

Abstract

The affinity of normorphine for its pharmacologic receptor was determined using the longitudinal muscle-myenteric plexus preparation of naive and morphine-tolerant guinea pigs and the method of partial blockade of a fraction of the receptor population with the novel, irreversible opiate antagonist, beta-chlornaltrexamine. The normorphine concentration-response curve was antagonized by beta-chlornaltrexamine in a nonsurmountable fashion, at antagonist concentrations ranging from 6.0 to 15.0 nM in both naive and tolerant tissues. The dissociation constant (KA; reciprocal of affinity) of normorphine was found to be 1.54 (+/- 0.22) X 10(-6) M in naive and 2.30 (+/- 0.66) X 10(-6) M in morphine-tolerant ilea, values that did not differ significantly. The IC50 of normorphine was approximately one-sixth as large as KA in the naive, but was approximately equal to KA in the tolerant preparation. The stimulus-effect relation was nonlinear in both naive and tolerant ilea, but differed markedly in range in the two states. This study represents a direct pharmacological determination of the normorphine dissociation constant using concentration-response data; the values obtained agree well with those based on brain concentration in vivo and with data obtained in radioligand binding studies performed in the presence of sodium chloride. Furthermore, these results suggest that affinity changes may not be of major importance in the development of tolerance to opiates in this tissue and that the phenomenon of tolerance is probably related to changes in the postreceptor chain of events that lead to the measured effect.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306216

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2.

Authors:  K McConalogue; E F Grady; J Minnis; B Balestra; M Tonini; N C Brecha; N W Bunnett; C Sternini
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

2.  Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus.

Authors:  C Chavkin; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

3.  Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys.

Authors:  Lenka Hruba; Brett C Ginsburg; Lance R McMahon
Journal:  J Pharmacol Exp Ther       Date:  2012-06-20       Impact factor: 4.030

4.  The physiological relevance of low agonist affinity binding at opioid mu-receptors.

Authors:  J A Carroll; J S Shaw; A D Wickenden
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

5.  The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.

Authors:  Takashi Yamamoto; Padma Nair; Neil E Jacobsen; Peg Davis; Shou-wu Ma; Edita Navratilova; Sharif Moye; Josephine Lai; Henry I Yamamura; Todd W Vanderah; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2008-09-27       Impact factor: 7.446

Review 6.  Dynorphin--still an extraordinarily potent opioid peptide.

Authors:  Charles Chavkin
Journal:  Mol Pharmacol       Date:  2012-11-14       Impact factor: 4.436

7.  Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists.

Authors:  Takashi Yamamoto; Padma Nair; Peg Davis; Shou-wu Ma; Edita Navratilova; Sharif Moye; Suneeta Tumati; Josephine Lai; Todd W Vanderah; Henry I Yamamura; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2007-05-22       Impact factor: 7.446

8.  Estimation of opioid receptor agonist dissociation constants with beta-chlornaltrexamine, an irreversible ligand which also displays agonism.

Authors:  P Leff; I G Dougall
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

9.  Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain.

Authors:  Ruben Vardanyan; Gokhale Vijay; Gary S Nichol; Lu Liu; Isuru Kumarasinghe; Peg Davis; Todd Vanderah; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  Bioorg Med Chem       Date:  2009-06-02       Impact factor: 3.641

10.  A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.

Authors:  Takashi Yamamoto; Padma Nair; Josef Vagner; Tally Largent-Milnes; Peg Davis; Shou-Wu Ma; Edita Navratilova; Sharif Moye; Suneeta Tumati; Josephine Lai; Henry I Yamamura; Todd W Vanderah; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2008-02-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.